ConductScience.org, home

Paper40329432

Trends in Antipsychotic Polypharmacy and Potential Overtreatment with Antipsychotics: A Naturalistic Cohort Study of People in Long-term Care.

Crutzen S and 8 others. Schizophr Bull, 2026. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Trends in Antipsychotic Polypharmacy and Potential Overtreatment with Antipsychotics: A Naturalistic Cohort Study of People in Long-term Care. Papers, record 40329432. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40329432

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Trends in Antipsychotic Polypharmacy and Potential Overtreatment with Antipsychotics: A Naturalistic Cohort Study of People in Long-term Care.
PubMed
Journal
Schizophr Bull
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-09-20
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Crutzen SStijnhttps://orcid.org/0000-0002-0537-0858
2Gangadin SShiralhttps://orcid.org/0000-0002-0084-8226
3Hua KHKen Ho
4Visser EEllen
5Jörg FFrederike
6van der Meer LLisette
7Pijnenborg GHMGerdina Hendrika Maria
8Veling WWim
9Castelein SStynkehttps://orcid.org/0000-0002-8419-568X

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
PolypharmacyMajor topic
Long-Term CareMajor topic
Medical OveruseMajor topic
Humans
Female
Male
Middle Aged
Longitudinal Studies
Aged
Adult
Sweden
Cohort Studies

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123936389Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials.PLoS One2013https://conductscience.org/library/papers/23936389PubMed
230862219Antipsychotic treatment - a systematic literature review and meta-analysis of qualitative studies.J Ment Health2020https://conductscience.org/library/papers/30862219PubMed
326256007Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study.Eur Neuropsychopharmacol2015https://conductscience.org/library/papers/26256007PubMed
428237639Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis.Lancet Psychiatry2017https://conductscience.org/library/papers/28237639PubMed
528735640Dose equivalents for second generation long-acting injectable antipsychotics: The minimum effective dose method.Schizophr Res2018https://conductscience.org/library/papers/28735640PubMed
634126462Factors predicting high-dose and combined antipsychotic prescribing in New Zealand: High-dose antipsychotic prescribing.Psychiatry Res2021https://conductscience.org/library/papers/34126462PubMed
734406325Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia: A Meta-analysis.JAMA Psychiatry2021https://conductscience.org/library/papers/34406325PubMed
831182319Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis.Schizophr Res2019https://conductscience.org/library/papers/31182319PubMed
915741458Remission in schizophrenia: proposed criteria and rationale for consensus.Am J Psychiatry2005https://conductscience.org/library/papers/15741458PubMed
1035524619Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors.World Psychiatry2022https://conductscience.org/library/papers/35524619PubMed
1129856543What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?World Psychiatry2018https://conductscience.org/library/papers/29856543PubMed
1232867516The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.Am J Psychiatry2020https://conductscience.org/library/papers/32867516PubMed
1317012982Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries.Int Clin Psychopharmacol2006https://conductscience.org/library/papers/17012982PubMed
1430785608Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.JAMA Psychiatry2019https://conductscience.org/library/papers/30785608PubMed
1533417992Dose-dependent effects of antipsychotics on efficacy and adverse effects in schizophrenia.Behav Brain Res2021https://conductscience.org/library/papers/33417992PubMed
1619133060High-dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) studies.Br J Clin Pharmacol2009https://conductscience.org/library/papers/19133060PubMed
1720360319International consensus study of antipsychotic dosing.Am J Psychiatry2010https://conductscience.org/library/papers/20360319PubMed
1829387876Mortality Rates After the First Diagnosis of Psychotic Disorder in Adolescents and Young Adults.JAMA Psychiatry2018https://conductscience.org/library/papers/29387876PubMed
1924923760
Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China.
Aust N Z J Psychiatry2015https://conductscience.org/library/papers/24923760PubMed
2031838873Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.Am J Psychiatry2020https://conductscience.org/library/papers/31838873PubMed

See all 45 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42447169Psychiatric nurses versus psychiatrists and pharmacists 'knowledge on polypharmacy practices in psychiatry: An interprofessional mixed-methods exploration.PLoS One2026https://conductscience.org/library/papers/42447169PubMed
40801808The Association of Antipsychotic Treatment and Side Effects With Societal Recovery and Happiness: A Naturalistic Cohort Study of People in Long-term Care for a Psychotic Disorder.Schizophr Bull2026https://conductscience.org/library/papers/40801808PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40329432

GET https://conductscience.org/api/papers/v1/40329432/references?page=2